Stockscreener 앱 받기
90.09
1.60%
-1.56
Incyte Corp 주식(INCY)의 최신 뉴스
Incyte (INCY) Rating Reiterated and Price Target Raised by Truis - GuruFocus
Wells Fargo Raises Incyte (INCY) Price Target to $97.00 | INCY S - GuruFocus
Incyte (INCY): Barclays Raises Price Target to $101 with Overwei - GuruFocus
Incyte Corporation (NASDAQ:INCY) Q3 2025 Earnings Call Transcript - Insider Monkey
How Incyte Corporation stock responds to policy changes2025 Valuation Update & Safe Capital Growth Tips - newser.com
INCY Q3 Deep Dive: Strong Product Momentum and Pipeline Reshaping Amid Strategic Refocus - Yahoo! Finance Canada
How Investors Are Reacting To Incyte (INCY) Surging Q3 Earnings and Promising Late-Stage Trial Data - Yahoo! Finance Canada
Incyte: Q3 Earnings Snapshot - Stamford Advocate
Incyte Walloped Third-Quarter Profit Views. Why Shares Fell. - Investor's Business Daily
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms - Benzinga
1 Growth Stock Under $100 to Buy Before It Soars - Yahoo Finance
Bank of America Securities Maintains a Buy on Incyte Corporation (INCY) - Insider Monkey
Incyte (INCY) Sees Strong Growth with Key Products and Raises Gu - GuruFocus
Incyte stock price target raised to $109 by BofA on strong Jakafi sales - Investing.com
INCY's Q3 Earnings & Revenues Beat Estimates on Higher Product Sales - Yahoo Finance
Incyte Raises Sales Targets But Investors Aren’t Cheering - Finimize
Incyte (INCY) PT Raised to $109 at BofA Securities - StreetInsider
Incyte Q3 2025 slides: Revenue jumps 20% as product portfolio expands - Investing.com
Earnings call transcript: Incyte Q3 2025 beats forecasts, stock surges - Investing.com
Incyte Outpaces Expectations And Raises Its Revenue Forecast - Finimize
Incyte (INCY) Boosts 2025 Revenue Forecast on Strong Product Dem - GuruFocus
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates - BioSpace
Why Incyte Corporation (ICY) stock stays resilientWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Incyte Corp (INCY) Q3 2025 Earnings: EPS of $2.11 Beats Estimates, Revenue Surges to $1.37 Billion - GuruFocus
Incyte shares rise as third quarter results beat expectations, guidance raised By Investing.com - Investing.com South Africa
Incyte shares rise as third quarter results beat expectations, guidance raised - Investing.com
Incyte releases new data from Phase IIIb trial of Opzelura in dermatitis - The Pharma Letter
Incyte earnings beat by $0.67, revenue topped estimates - Investing.com
Incyte Reports Third Quarter 2025 Financial Results - TradingView
Can Incyte Corporation (ICY) stock attract analyst upgradesJuly 2025 Big Picture & Technical Pattern Recognition Alerts - newser.com
Can a trend reversal in Incyte Corporation lead to recoveryInflation Watch & Daily Oversold Bounce Ideas - newser.com
Can Incyte Corporation stock hit record highs againTrade Performance Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-28 01:35:50 - newser.com
Will Incyte Corporation (ICY) stock enhance shareholder value2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Using Python tools to backtest Incyte Corporation strategiesQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Does Incyte Corporation show high probability of reboundWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com
What risks investors should watch in Incyte Corporation stockBreakout Watch & High Accuracy Swing Trade Signals - newser.com
Incyte Corporation stock hits 52-week high at 92.92 USD - Investing.com
Incyte Corp. Experiences Valuation Adjustment Amid Strong Market Performance and Competitive Positioning - Markets Mojo
Is Incyte Corporation stock attractive after correction2025 Macro Impact & Community Consensus Stock Picks - Fundação Cultural do Pará
Incyte (INCY) Poised for Q3 Earnings Upsurge - GuruFocus
How Incyte Corporation stock performs in rising dollar environmentPortfolio Value Summary & Expert Approved Momentum Ideas - newser.com
Incyte partners with Enable Injections to develop drug delivery system - Investing.com
Incyte (INCY) Joins Forces with Enable for Innovative Drug Deliv - GuruFocus
Incyte (NASDAQ: INCY) partners with Enable for enFuse use in mutCALR therapy for ET and MF - Stock Titan
Multi asset correlation models including Incyte CorporationWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Is Incyte Corporation (ICY) stock dividend growth reliableJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
How Incyte Corporation stock compares to market leaders2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
What’s next for Incyte Corporation stock priceVolume Spike & Community Verified Swing Trade Signals - newser.com
Is Incyte Corporation (ICY) stock undervalued by metricsTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Will Incyte Corporation (ICY) stock see insider accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Real time alert setup for Incyte Corporation performanceJuly 2025 WrapUp & Community Trade Idea Sharing Platform - newser.com
0.10%
0.95%
자본화:
|
볼륨(24시간):